Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma.

ABSTRACT:

SUBMITTER: Teng F 

PROVIDER: S-EPMC10542228 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature